News

A new drug is showing promise as a treatment for mesothelioma - one of the most lethal cancers of all.

Scientists discover link between broccoli component and improved drug efficacy.

Landmark preclinical study cured lung metastases in 50 percent of breast cancers by making nanoparticles inside the tumor.

An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment, according to a Cancer Research UK-funded study.

Kanazawa University researchers find similarities in the impeded signalling between central insulin activity and glucose production in the liver for both obese mice and mice that have had the vagus nerve removed.

Researchers at Stanford University have found excessive glucose uptake by inflammatory immune cells called macrophages, which reside in arterial plaques, may be behind coronary artery disease.

Nanotechnology-based delivery system developed to control a variety of skin pathologies and disorders.

Company has signed collaboration agreement with True Diagnostics for novel biologics tests.

Company has announced collaboration with DNA Software Inc. to develop high-multiplex infectious disease panels for commercialization on InSilixa’s CMOS biochip platform.

Company has announced that it has been acquired by Spark Therapeutics, Inc. to expedite the clinical development of RhoNova™ for the treatment of RHO-adRP.